Investment Thesis
Encision Inc faces severe operational challenges with negative operating margins (-8.9%), negative net margins (-9.9%), and deteriorating profitability despite maintaining a healthy gross margin of 50.3%. The company is burning cash with negative operating cash flow (-$242.1K) and negative free cash flow (-$285.4K), while cash reserves are critically low at $71.7K, creating substantial solvency risk. Revenue contraction (-0.5% YoY) combined with inability to achieve profitability indicates fundamental business model stress.
Strengths
- Solid gross margin of 50.3% indicates reasonable pricing power and cost of goods control
- Healthy current ratio of 2.28x suggests adequate short-term liquidity for immediate obligations
- Low leverage with debt-to-equity ratio of 0.08x provides minimal default risk from debt obligations
Risks
- Critical cash burn with negative operating cash flow and dangerously low cash balance ($71.7K) creates imminent liquidity crisis
- Persistent unprofitability with negative operating income (-$278.3K) and negative net income (-$309.0K) indicates operational dysfunction
- Revenue stagnation (-0.5% YoY) combined with inability to control operating expenses suggests deteriorating competitive position in medical device sector
- Negative interest coverage ratio (-4.5x) indicates inability to service debt obligations from operations
- Zero insider buying activity in last 90 days suggests lack of management confidence in company prospects
Key Metrics to Watch
- Operating cash flow trend - any further deterioration accelerates insolvency risk
- Cash balance depletion rate and runway to require financing or restructuring
- Revenue stabilization and operating expense reduction to achieve profitability inflection
- Gross margin sustainability as potential indicator of market competitiveness
Financial Metrics
Revenue
3.1M
Net Income
-309.0K
EPS (Diluted)
$-0.02
Free Cash Flow
-285.4K
Total Assets
4.1M
Cash
71.7K
Profitability Ratios
Gross Margin
50.3%
Operating Margin
-8.9%
Net Margin
-9.9%
ROE
-16.6%
ROA
-7.6%
FCF Margin
-9.1%
Balance Sheet & Liquidity
Current Ratio
2.28x
Quick Ratio
0.91x
Debt/Equity
0.08x
Debt/Assets
54.0%
Interest Coverage
-4.46x
Long-term Debt
152.0K
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-24T00:44:12.933906 |
Data as of: 2025-09-30 |
Powered by Claude AI